Works matching IS 09509232 AND DT 2013 AND VI 32 AND IP 25

Results: 10

MiR-181a confers resistance of cervical cancer to radiation therapy through targeting the pro-apoptotic PRKCD gene.

Published in:

Oncogene, 2013, v. 32, n. 25, p. 3019, doi. 10.1038/onc.2012.323

By:

Ke, G;
Liang, L;
Yang, J M;
Huang, X;
Han, D;
Huang, S;
Zhao, Y;
Zha, R;
He, X;
Wu, X

Publication type:

Article

Erg and AP-1 as determinants of glucocorticoid response in acute lymphoblastic leukemia.

Published in:

Oncogene, 2013, v. 32, n. 25, p. 3039, doi. 10.1038/onc.2012.321

By:

Chen, D W-C;
Saha, V;
Liu, J-Z;
Schwartz, J-M;
Krstic-Demonacos, M

Publication type:

Article

Integrin β5 contributes to the tumorigenic potential of breast cancer cells through the Src-FAK and MEK-ERK signaling pathways.

Published in:

Oncogene, 2013, v. 32, n. 25, p. 3049, doi. 10.1038/onc.2012.320

By:

Bianchi-Smiraglia, A;
Paesante, S;
Bakin, A V

Publication type:

Article

Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas.

Published in:

Oncogene, 2013, v. 32, n. 25, p. 3091, doi. 10.1038/onc.2012.315

By:

Wang, P;
Dong, Q;
Zhang, C;
Kuan, P-F;
Liu, Y;
Jeck, W R;
Andersen, J B;
Jiang, W;
Savich, G L;
Tan, T-X;
Auman, J T;
Hoskins, J M;
Misher, A D;
Moser, C D;
Yourstone, S M;
Kim, J W;
Cibulskis, K;
Getz, G;
Hunt, H V;
Thorgeirsson, S S

Publication type:

Article

MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6R.

Published in:

Oncogene, 2013, v. 32, n. 25, p. 3071, doi. 10.1038/onc.2012.318

By:

Gong, J;
Zhang, J-P;
Li, B;
Zeng, C;
You, K;
Chen, M-X;
Yuan, Y;
Zhuang, S-M

Publication type:

Article

Transducer of Cdc42-dependent actin assembly promotes breast cancer invasion and metastasis.

Published in:

Oncogene, 2013, v. 32, n. 25, p. 3080, doi. 10.1038/onc.2012.317

By:

Chander, H;
Truesdell, P;
Meens, J;
Craig, A W B

Publication type:

Article

NRAS mutant melanoma: biological behavior and future strategies for therapeutic management.

Published in:

Oncogene, 2013, v. 32, n. 25, p. 3009, doi. 10.1038/onc.2012.453

By:

Fedorenko, I V;
Gibney, G T;
Smalley, K S M

Publication type:

Article

Tumour cell responses to new fibroblast growth factor receptor tyrosine kinase inhibitors and identification of a gatekeeper mutation in FGFR3 as a mechanism of acquired resistance.

Published in:

Oncogene, 2013, v. 32, n. 25, p. 3059, doi. 10.1038/onc.2012.319

By:

Chell, V;
Balmanno, K;
Little, A S;
Wilson, M;
Andrews, S;
Blockley, L;
Hampson, M;
Gavine, P R;
Cook, S J

Publication type:

Article

C-terminal phosphorylation of Hsp70 and Hsp90 regulates alternate binding to co-chaperones CHIP and HOP to determine cellular protein folding/degradation balances.

Published in:

Oncogene, 2013, v. 32, n. 25, p. 3101, doi. 10.1038/onc.2012.314

By:

Muller, P;
Ruckova, E;
Halada, P;
Coates, P J;
Hrstka, R;
Lane, D P;
Vojtesek, B

Publication type:

Article

Selection for Evi1 activation in myelomonocytic leukemia induced by hyperactive signaling through wild-type NRas.

Published in:

Oncogene, 2013, v. 32, n. 25, p. 3028, doi. 10.1038/onc.2012.329

By:

Wolf, S;
Rudolph, C;
Morgan, M;
Büsche, G;
Salguero, G;
Stripecke, R;
Schlegelberger, B;
Baum, C;
Modlich, U

Publication type:

Article